Abstract
Introduction: Quadriceps strength and size are commonly reduced in chronic obstructive pulmonary disease (COPD). We wished to assess volitional and nonvolitional ankle dorsiflexor strength in COPD. Methods: Quadriceps and ankle dorsiflexor strength were measured by maximum voluntary contraction (MVC) and by twitch responses to supramaximal femoral and fibular nerve stimulation. Cross‐sectional areas of the tibialis anterior (TACSA) and rectus femoris muscles (RFCSA) were measured by ultrasound. Results: Eighteen elderly subjects and 20 COPD patients [mean(SD) %predictedFEV1 50(20)%] participated. No significant difference in fat‐free mass index, ankle dorsiflexor strength, or TACSA were observed in the presence of reduced quadriceps strength and size in COPD [mean MVC difference: −10.9 kg (95% confidence interval {CI}: −17.1 kg to −4.8 kg, P < 0.01; mean RFCSA difference −119 mm2, 95% CI: −180 mm2 to −58 mm2, P < 0.01)]. Conclusions: Ankle dorsiflexor strength is less attenuated than quadriceps strength in COPD patients with moderate airflow obstruction. Direct quadriceps assessment may be more relevant than measurement of lower limb fat‐free mass. Muscle Nerve 46: 548–554, 2012
Funding Information
  • British Lung Foundation (BLF P04/8)
  • GlaxoSmithKline UK
  • NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London

This publication has 39 references indexed in Scilit: